Top-Rated StocksTop-RatedPositive News SentimentPositive NewsNASDAQ:HQY HealthEquity (HQY) Stock Price, News & Analysis → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free HQY Stock Alerts $80.07 -1.12 (-1.38%) (As of 02:53 PM ET) Add Compare Share Share Today's Range$80.04▼$81.5650-Day Range$78.55▼$83.5352-Week Range$48.86▼$84.49Volume196,878 shsAverage Volume596,266 shsMarket Capitalization$6.87 billionP/E Ratio125.11Dividend YieldN/APrice Target$96.17 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get HealthEquity alerts: Email Address HealthEquity MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside20.0% Upside$96.17 Price TargetShort InterestHealthy3.47% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.72Based on 3 Articles This WeekInsider TradingSelling Shares$5.68 M Sold Last QuarterProj. Earnings Growth31.60%From $2.12 to $2.79 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.08 out of 5 starsMedical Sector170th out of 910 stocksBusiness Services, Not Elsewhere Classified Industry27th out of 87 stocks 3.5 Analyst's Opinion Consensus RatingHealthEquity has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 11 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageHealthEquity has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.47% of the outstanding shares of HealthEquity have been sold short.Short Interest Ratio / Days to CoverHealthEquity has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in HealthEquity has recently decreased by 1.97%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldHealthEquity does not currently pay a dividend.Dividend GrowthHealthEquity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HQY. Previous Next 3.2 News and Social Media Coverage News SentimentHealthEquity has a news sentiment score of 1.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for HealthEquity this week, compared to 5 articles on an average week.Search InterestOnly 4 people have searched for HQY on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat Follows4 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, HealthEquity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,682,895.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of HealthEquity is held by insiders.Percentage Held by Institutions99.55% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for HealthEquity are expected to grow by 31.60% in the coming year, from $2.12 to $2.79 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of HealthEquity is 125.27, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 138.81.Price to Earnings Ratio vs. SectorThe P/E ratio of HealthEquity is 125.27, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 198.45.Price to Earnings Growth RatioHealthEquity has a PEG Ratio of 1.32. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHealthEquity has a P/B Ratio of 3.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. About HealthEquity Stock (NASDAQ:HQY)HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.Read More HQY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HQY Stock News HeadlinesMarch 29, 2024 | insidertrades.comInsider Selling: HealthEquity, Inc. (NASDAQ:HQY) Director Sells 32,500 Shares of StockMarch 27, 2024 | insidertrades.comInsider Selling: HealthEquity, Inc. (NASDAQ:HQY) CEO Sells 33,765 Shares of StockApril 23, 2024 | The TradingPub (Ad)At first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”April 15, 2024 | nasdaq.comHQY Quantitative Stock AnalysisApril 4, 2024 | globenewswire.comBenefits Leaders Believe in Power of AI, Considering Data Privacy and AccuracyApril 4, 2024 | markets.businessinsider.comHealthEquity’s Market Leadership and Growth Trajectory Bolster Buy RatingMarch 29, 2024 | finance.yahoo.comDirector Evelyn Dilsaver Sells 32,500 Shares of HealthEquity Inc (HQY)March 28, 2024 | markets.businessinsider.comJefferies Keeps Their Buy Rating on Healthequity (HQY)April 23, 2024 | WealthPress (Ad)The system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.March 28, 2024 | markets.businessinsider.comBuy Rating on Healthequity (HQY) Affirmed Amid HSA Market Growth and Competitive OutperformanceMarch 24, 2024 | finance.yahoo.comHealthEquity Full Year 2024 Earnings: EPS Beats ExpectationsMarch 22, 2024 | markets.businessinsider.comHealthEquity Outperforms with Strong Quarterly Results and Positive Fiscal 2025 Outlook: Buy Rating ReaffirmedMarch 21, 2024 | seekingalpha.comHealthEquity, Inc. (HQY) Q4 2024 Earnings Call TranscriptMarch 21, 2024 | seekingalpha.comHealthEquity: Multiple Compression Has Finally Made It A BuyMarch 20, 2024 | msn.comHealthEquity, Inc. (NASDAQ:HQY) Q4 2024 Earnings Call TranscriptMarch 20, 2024 | msn.comHealthEquity Maintains Fiscal 2025 Revenue Outlook Following Fourth-Quarter BeatMarch 20, 2024 | markets.businessinsider.comBarclays Keeps Their Buy Rating on Healthequity (HQY)March 19, 2024 | investorplace.comHQY Stock Earnings: HealthEquity Beats EPS, Beats Revenue for Q4 2024March 19, 2024 | benzinga.comRecap: HealthEquity Q4 EarningsMarch 19, 2024 | finance.yahoo.comHealthEquity Inc (HQY) Reports Strong Fiscal Year 2024 Earnings with Revenue Up 16%March 19, 2024 | globenewswire.comHealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial ResultsMarch 18, 2024 | markets.businessinsider.comHere's what to expect from HealthEquity's earnings reportMarch 18, 2024 | msn.comHealthEquity Q4 2024 Earnings PreviewMarch 18, 2024 | entrepreneur.comHQY Pre-Earnings Assessment: Should You Invest in HealthEquity?March 18, 2024 | benzinga.comEarnings Outlook For HealthEquityMarch 15, 2024 | finance.yahoo.comShould You Be Confident in HealthEquity (HQY)?March 14, 2024 | finance.yahoo.comHealthEquity's (NASDAQ:HQY) investors will be pleased with their decent 48% return over the last yearSee More Headlines Receive HQY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/19/2024Today4/23/2024Next Earnings (Estimated)6/03/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Business services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:HQY CUSIPN/A CIK1428336 Webwww.healthequity.com Phone(801) 727-1000Fax801-727-1005Employees3,150Year FoundedN/APrice Target and Rating Average Stock Price Target$96.17 High Stock Price Target$110.00 Low Stock Price Target$72.00 Potential Upside/Downside+18.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$0.64 Trailing P/E Ratio127.16 Forward P/E Ratio38.39 P/E Growth1.32Net Income$55.71 million Net Margins5.57% Pretax Margin7.51% Return on Equity6.91% Return on Assets4.41% Debt Debt-to-Equity Ratio0.43 Current Ratio4.76 Quick Ratio4.76 Sales & Book Value Annual Sales$999.59 million Price / Sales6.99 Cash Flow$3.44 per share Price / Cash Flow23.66 Book Value$23.72 per share Price / Book3.43Miscellaneous Outstanding Shares85,800,000Free Float83,483,000Market Cap$6.98 billion OptionableOptionable Beta0.53 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Jon Kessler (Age 56)President, CEO & Director Comp: $1.55MDr. Stephen D. Neeleman (Age 56)Founder & Vice Chairman Comp: $770.67kMr. Elimelech Rosner (Age 67)Executive VP & CTO Comp: $1.74MMr. James M. Lucania (Age 45)CFO & Executive VP Ms. Angelique Christine Hill (Age 55)Executive Vice President of Operations Mr. Richard PutnamVice President of Investor RelationsMr. Delano Ladd (Age 43)Executive VP, General Counsel & Secretary Comp: $319.48kMr. Steve LindsayExecutive Vice President of Sales & Relationship ManagementMr. Brad BennionSenior Vice President of Corporate DevelopmentMs. Tia PadiaExecutive VP & Chief Marketing OfficerMore ExecutivesKey CompetitorsJazz PharmaceuticalsNASDAQ:JAZZExelixisNASDAQ:EXELGlobus MedicalNYSE:GMEDVaxcyteNASDAQ:PCVXElanco Animal HealthNYSE:ELANView All CompetitorsInsiders & InstitutionsGradient Investments LLCSold 3,756 shares on 4/23/2024Ownership: 0.063%Amalgamated BankSold 8,677 shares on 4/23/2024Ownership: 0.052%Raymond James Financial Services Advisors Inc.Sold 21,616 shares on 4/23/2024Ownership: 0.023%KLR Investment Advisors LLCSold 492 shares on 4/23/2024Ownership: 0.006%Raymond James & AssociatesSold 36,316 shares on 4/22/2024Ownership: 0.156%View All Insider TransactionsView All Institutional Transactions HQY Stock Analysis - Frequently Asked Questions Should I buy or sell HealthEquity stock right now? 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HQY shares. View HQY analyst ratings or view top-rated stocks. What is HealthEquity's stock price target for 2024? 11 Wall Street analysts have issued 1-year price targets for HealthEquity's stock. Their HQY share price targets range from $72.00 to $110.00. On average, they predict the company's stock price to reach $96.17 in the next twelve months. This suggests a possible upside of 20.0% from the stock's current price. View analysts price targets for HQY or view top-rated stocks among Wall Street analysts. How have HQY shares performed in 2024? HealthEquity's stock was trading at $66.30 at the beginning of the year. Since then, HQY shares have increased by 20.9% and is now trading at $80.17. View the best growth stocks for 2024 here. When is HealthEquity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, June 3rd 2024. View our HQY earnings forecast. How were HealthEquity's earnings last quarter? HealthEquity, Inc. (NASDAQ:HQY) released its quarterly earnings results on Tuesday, March, 19th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.08. The company earned $262.39 million during the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a net margin of 5.57% and a trailing twelve-month return on equity of 6.91%. What ETFs hold HealthEquity's stock? ETFs with the largest weight of HealthEquity (NASDAQ:HQY) stock in their portfolio include Aztlan Global Stock Selection DM SMID ETF (AZTD), Motley Fool Small-Cap Growth ETF (TMFS), MFAM Small-Cap Growth ETF (MFMS), Motley Fool Mid-Cap Growth ETF (TMFM), Global X FinTech Thematic ETF (FINX), SPDR S&P Health Care Services ETF (XHS), Nuveen Small Cap Select ETF (NSCS) and Putnam Sustainable Future ETF (PFUT). What guidance has HealthEquity issued on next quarter's earnings? HealthEquity updated its FY 2025 earnings guidance on Thursday, April, 11th. The company provided EPS guidance of 2.790-2.960 for the period, compared to the consensus estimate of 2.830. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. What is Jon Kessler's approval rating as HealthEquity's CEO? 359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend. What other stocks do shareholders of HealthEquity own? Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP). Who are HealthEquity's major shareholders? HealthEquity's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Wasatch Advisors LP (8.64%), Allspring Global Investments Holdings LLC (1.30%), Vaughan Nelson Investment Management L.P. (0.71%), Raymond James & Associates (0.16%), Inspirion Wealth Advisors LLC (0.09%) and Gradient Investments LLC (0.06%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Evelyn S Dilsaver, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten. View institutional ownership trends. How do I buy shares of HealthEquity? Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HQY) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthEquity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
